The pathway would create a standardized process for authorizing experimental treatments and, importantly, offering companies the possibility of commercializing them.
WASHINGTON (AP) — Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the pharmaceutical industry has long considered unprofitable.
Additional Reads
Read Full Article: https://www.courthousenews.com/fda-proposes-new-system-for-approving-customized-drugs-and-therapies-for-rare-diseases/
